Enhancing adherence to inhaled therapies in cystic fibrosis

  title={Enhancing adherence to inhaled therapies in cystic fibrosis},
  author={P. Lomas},
  journal={Therapeutic Advances in Respiratory Disease},
  pages={39 - 47}
  • P. Lomas
  • Published 2014
  • Medicine
  • Therapeutic Advances in Respiratory Disease
  • Nonadherence to inhaled therapies is a major problem in the treatment of cystic fibrosis that can influence lung function and health outcomes. Potential contributors to nonadherence have been identified, including demographic and psychosocial factors, time and convenience of inhaled therapy, and treatment beliefs. Additional research is clearly needed to clarify the contributors and to determine which interventions and technological advances will enhance adherence to inhaled therapies in… CONTINUE READING
    17 Citations

    Tables and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Adherence to therapies in cystic fibrosis: a targeted literature review
    • 32
    Aerosol delivery practice in Italian Cystic Fibrosis centres: a national survey
    II. Topic Sessions
    Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients.
    • 15


    Adherence to the medical regimen: clinical implications of new findings
    • 28
    Motivational interviewing for adherence problems in cystic fibrosis
    • 56
    Non-adherence to treatment in cystic fibrosis.
    • B. Lask
    • Medicine
    • Journal of the Royal Society of Medicine
    • 1994
    • 45
    Impact of age and gender on adherence to infection control guidelines and medical regimens in cystic fibrosis
    • 41
    Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way?
    • 257
    • PDF